Krystal Biotech To Present At Upcoming Investor Conferences

Krystal Biotech Inc., (?Krystal?) (NASDAQ: KRYS), a fully integrated gene therapy company driven by its proprietary, engineered herpes simplex virus t


more on businesswire.com